Lenox Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Lenox Wealth Advisors's GILD Position: Q1 2022 in Review
Lenox Wealth Advisors sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 64 shares — an estimated $5K sold.
Lenox Wealth Advisors first reported a position in GILD in Q2 2013 and held it in 22 quarters. The position peaked at $69K in Q4 2017. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Lenox Wealth Advisors reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- Lenox Wealth Advisors sold 64 Gilead Sciences shares in Q1 2022, an estimated $5K.
- Lenox Wealth Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 22 quarters.
- Lenox Wealth Advisors's Gilead Sciences position peaked at $69K in Q4 2017.
- 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.